UBS Group AG - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$11,084,254
+2052.3%
411,137
+1337.1%
0.00%
Q3 2022$515,000
-50.7%
28,608
-66.0%
0.00%
Q2 2022$1,044,000
-48.4%
84,068
-44.6%
0.00%
-100.0%
Q1 2022$2,022,000
-44.7%
151,781
-35.3%
0.00%0.0%
Q4 2021$3,655,000
+19.3%
234,728
+71.9%
0.00%0.0%
Q3 2021$3,064,000
+87.3%
136,538
+90.0%
0.00%0.0%
Q2 2021$1,636,000
-34.0%
71,849
-40.4%
0.00%0.0%
Q1 2021$2,479,000
-59.6%
120,463
-45.8%
0.00%
-50.0%
Q4 2020$6,143,000
+330.2%
222,416
+118.8%
0.00%
+100.0%
Q3 2020$1,428,000
+365.1%
101,664
+583.0%
0.00%
Q2 2020$307,000
+802.9%
14,886
+235.5%
0.00%
Q1 2020$34,000
-81.8%
4,437
-63.1%
0.00%
Q4 2019$187,000
+405.4%
12,035
+68.3%
0.00%
Q3 2019$37,000
+640.0%
7,150
+1219.2%
0.00%
Q2 2019$5,000
-82.1%
542
-54.5%
0.00%
Q1 2019$28,000
+21.7%
1,192
-17.1%
0.00%
Q4 2018$23,000
-32.4%
1,438
+11.3%
0.00%
Q3 2018$34,000
+54.5%
1,292
+26.0%
0.00%
Q1 2018$22,000
+22.2%
1,025
-13.4%
0.00%
Q3 2017$18,000
+1700.0%
1,184
+929.6%
0.00%
Q2 2017$1,000
-95.0%
115
-93.4%
0.00%
Q1 2017$20,000
-47.4%
1,743
-42.4%
0.00%
Q4 2016$38,0003,0250.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 85,000$1,132,0001.20%
Bellevue Group AG 5,859,039$78,042,0000.91%
APIS CAPITAL ADVISORS, LLC 40,000$533,0000.64%
Pier Capital, LLC 294,954$3,929,0000.50%
Resolute Capital Asset Partners LLC 50,000$666,0000.42%
Rhenman & Partners Asset Management AB 249,300$3,321,0000.33%
Hennion & Walsh Asset Management, Inc. 409,079$5,449,0000.29%
TORRAY INVESTMENT PARTNERS LLC 79,868$1,064,0000.17%
PLATINUM INVESTMENT MANAGEMENT LTD 195,211$2,600,0000.08%
DUALITY ADVISERS, LP 54,164$721,0000.08%
View complete list of MYOVANT SCIENCES LTD shareholders